{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:04:40Z","timestamp":1789448680373,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/hjh.0000000000000059","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T14:57:35Z","timestamp":1386255455000},"page":"542-554","source":"Crossref","is-referenced-by-count":43,"title":["Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats"],"prefix":"10.1097","volume":"32","author":[{"given":"Camilla F.","family":"Wenceslau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana V.","family":"Rossoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210208","doi-asserted-by":"crossref","first-page":"C1367","DOI":"10.1152\/ajpcell.1993.264.6.C1367","article-title":"Physiological effects of endogenous ouabain: control of intra-celular Ca2 stores and cell responsiveness.","volume":"264","author":"Blaustein","year":"1993","journal-title":"Am J Physiol"},{"key":"R2-15-20210208","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10641969809053247","article-title":"The cellular mechanism of action of cardiotonic steroids: a new hypothesis.","volume":"20","author":"Blaustein","year":"1998","journal-title":"Clin Exp Hypertens"},{"key":"R3-15-20210208","first-page":"F633","article-title":"Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function.","volume":"275","author":"Blanco","year":"1998","journal-title":"Am J Physiol"},{"key":"R4-15-20210208","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-physiol-021909-135725","article-title":"The physiological significance of the cardiotonic steroidouabain-binding site of the Na,K-ATPase.","volume":"72","author":"Lingrel","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"R5-15-20210208","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1074\/jbc.274.27.19323","article-title":"Intracellular reactive oxygen species mediate the linkage of Na-K-ATPase to hypertrophy and its marker genes in cardiac myocytes.","volume":"274","author":"Xie","year":"1999","journal-title":"J Biol Chem"},{"key":"R6-15-20210208","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mi.3.3.157","article-title":"Na-K-ATPase-mediated signal transduction: from protein interaction to cellular function.","volume":"3","author":"Xie","year":"2003","journal-title":"Mol Interv"},{"key":"R7-15-20210208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.86.2.420","article-title":"Elevated concentration of endogenous ouabain in patients with congestive heart failure.","volume":"86","author":"Gottlieb","year":"1992","journal-title":"Circulation"},{"key":"R8-15-20210208","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0024-3205(76)90284-8","article-title":"The role of humoral agents in volume expanded hypertension.","volume":"19","author":"Haddy","year":"1976","journal-title":"Life Sci"},{"key":"R9-15-20210208","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/300650a0","article-title":"A circulating inhibitor of (Na,K)-ATPase associated with essential hypertension.","volume":"300","author":"Hamlyn","year":"1982","journal-title":"Nature"},{"key":"R10-15-20210208","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejheart.2005.07.010","article-title":"Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy.","volume":"8","author":"Pitzalis","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R11-15-20210208","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2007.01883.x","article-title":"Endogenous ouabain and cardiomyopathy in dialysis patients.","volume":"263","author":"Stella","year":"2008","journal-title":"J Intern Med"},{"key":"R12-15-20210208","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00004872-199510000-00013","article-title":"Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.","volume":"13","author":"Rossi","year":"1995","journal-title":"J Hypertens"},{"key":"R13-15-20210208","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1210\/jcem-59-6-1070","article-title":"An endogenous ouabain-like factor associated with hypertensive pregnant women.","volume":"59","author":"Graves","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-15-20210208","doi-asserted-by":"crossref","first-page":"F797","DOI":"10.1152\/ajprenal.00248.2013","article-title":"Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.","volume":"305","author":"Blanco","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R15-15-20210208","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.HYP.22.2.178","article-title":"Long-term ouabain administration produces hypertension in rats.","volume":"22","author":"Yuan","year":"1993","journal-title":"Hypertension"},{"issue":"Suppl","key":"R16-15-20210208","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1291\/hypres.23.Supplement_S77","article-title":"Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin.","volume":"23","author":"Manunta","year":"2000","journal-title":"Hypertens Res"},{"key":"R17-15-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bjp.0704501","article-title":"Alterations in phenylephrine-induced contractions and the vascular expression of Na,K-ATPase in ouabain-induced hypertension.","volume":"135","author":"Rossoni","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R18-15-20210208","doi-asserted-by":"crossref","first-page":"H2110","DOI":"10.1152\/ajpheart.00454.2002","article-title":"Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors.","volume":"283","author":"Rossoni","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R19-15-20210208","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00004872-200405000-00017","article-title":"Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats.","volume":"22","author":"Xavier","year":"2004","journal-title":"J Hypertens"},{"key":"R20-15-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bjp.0705919","article-title":"Ouabain-induced hypertension alters the participation of endothelial factors in (-adrenergic responses differently in rat resistance and conductance mesenteric arteries.","volume":"143","author":"Xavier","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R21-15-20210208","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.bjp.0705994","article-title":"Contribution of the endothelin and renin angiotensin systems to the vascular changes in rats chronically treated with ouabain.","volume":"143","author":"Xavier","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R22-15-20210208","doi-asserted-by":"crossref","first-page":"H193","DOI":"10.1152\/ajpheart.00802.2005","article-title":"Alterations in structure and mechanics of resistance arteries from ouabain induced hypertensive rats.","volume":"291","author":"Briones","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R23-15-20210208","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000322576","article-title":"Long-term ouabain treatment impairs vascular function in resistance arteries.","volume":"48","author":"Wenceslau","year":"2011","journal-title":"J Vasc Res"},{"key":"R24-15-20210208","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.HYP.23.6.1087","article-title":"Chronic central versus peripheral ouabain blood pressure, and sympathetic activity in rats.","volume":"23","author":"Huang","year":"1994","journal-title":"Hypertension"},{"key":"R25-15-20210208","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/cs0910497","article-title":"Chronic sodium-potassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat.","volume":"91","author":"Kurashina","year":"1996","journal-title":"Clin Sci"},{"key":"R26-15-20210208","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.lfs.2006.04.017","article-title":"Ouabain-induced hypertension enhances left ventricular contractility in rats.","volume":"79","author":"Rossoni","year":"2006","journal-title":"Life Sci"},{"key":"R27-15-20210208","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/HJH.0b013e32832a391f","article-title":"Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.","volume":"27","author":"Xavier","year":"2009","journal-title":"J Hypertens"},{"key":"R28-15-20210208","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)37374-4","article-title":"PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.","volume":"285","author":"Ferrari","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R29-15-20210208","doi-asserted-by":"crossref","first-page":"33306","DOI":"10.1074\/jbc.M402187200","article-title":"Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238.","volume":"279","author":"Ferrandi","year":"2004","journal-title":"J Biol Chem"},{"key":"R30-15-20210208","doi-asserted-by":"crossref","first-page":"59ra86","DOI":"10.1126\/scitranslmed.3001815","article-title":"Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.","volume":"2","author":"Ferrandi","year":"2010","journal-title":"Sci Transl Med"},{"key":"R31-15-20210208","doi-asserted-by":"crossref","first-page":"R529","DOI":"10.1152\/ajpregu.00518.2005","article-title":"Rostafuroxin: a ouabain antagonist that corrects renal and vascular Na-K-ATPase alterations in ouabain and adducin-dependent hypertension.","volume":"290","author":"Ferrari","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physio"},{"key":"R32-15-20210208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ Res"},{"key":"R33-15-20210208","first-page":"198","article-title":"Potassium-induced relaxation as an indicator of NaKATPase activity in the vascular smooth muscle.","volume":"15","author":"Webb","year":"1978","journal-title":"Blood Vessels"},{"key":"R34-15-20210208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11906-010-0161-z","article-title":"Endogenous ouabain: a link between sodium intake and hypertension.","volume":"13","author":"Hamlyn","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"R35-15-20210208","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.HYP.34.3.450","article-title":"Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension.","volume":"4","author":"Manunta","year":"1999","journal-title":"Hypertension"},{"key":"R36-15-20210208","doi-asserted-by":"crossref","first-page":"H360","DOI":"10.1152\/ajpheart.1994.266.1.H360","article-title":"Ouabain in plasma from spontaneously hypertensive rats.","volume":"266","author":"Doris","year":"1994","journal-title":"Am J Physiol Renal Physiol"},{"key":"R37-15-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-291X(84)90449-2","article-title":"Circulating digitalis-like substance is increased in DOCA-salt hypertension.","volume":"122","author":"Kojima","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"R38-15-20210208","doi-asserted-by":"crossref","first-page":"59ra87","DOI":"10.1126\/scitranslmed.3001814","article-title":"Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.","volume":"2","author":"Lanzani","year":"2010","journal-title":"Sci Transl Med"},{"key":"R39-15-20210208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance H","volume":"44","author":"Touyz","year":"2004","journal-title":"ypertension"},{"key":"R40-15-20210208","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.221315298","article-title":"Ouabain, a steroid hormone that signals with slow calcium oscillations.","volume":"98","author":"Aizman","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"R41-15-20210208","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1096\/fj.02-0937fje","article-title":"Mechanisms of ouabain toxicity.","volume":"17","author":"Valente","year":"2003","journal-title":"Faseb J"},{"key":"R42-15-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.RES.85.1.23","article-title":"Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension.","volume":"85","author":"Fukai","year":"1999","journal-title":"Circ Res"},{"key":"R43-15-20210208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NAD(P)H oxidases: physiology and pathophysiology.","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"R44-15-20210208","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000033523.08033.16","article-title":"Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators.","volume":"91","author":"Seshiah","year":"2002","journal-title":"Circ Res"},{"key":"R45-15-20210208","doi-asserted-by":"crossref","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","article-title":"Cytokines and vascular reactivity in resistance arteries.","volume":"288","author":"Vila","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R46-15-20210208","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.freeradbiomed.2011.08.011","article-title":"Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway.","volume":"51","author":"Sancho","year":"2011","journal-title":"Free Radic Biol Med"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0000000000000059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:12:50Z","timestamp":1746065570000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201403000-00015"}},"subtitle":["the role of Na+K+-ATPase\/ cSRC pathway"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0000000000000059","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}